Small drugmakers can't scale up quickly enough to get ahead of the virus

Two overviews of efforts by drug makers to produce Ebola medication.

WASHINGTON POST                 Oct. 10, 014

by Lenny Bernstein and Brady Dennis

WASHINGTON ..."It takes time. You end up with a situation where the companies weren't set up to ramp up productio. You don't just go from that to making 10,000 does overnight."  -- Prof. Thomas Galsbert, University of Texas Medical Branch at Galveston.

Read full story

http://www.washingtonpost.com/national/health-science/small-drugmakers-try-to-scale-up-to-meet-ebola-crisis/2014/10/09/a594dec2-4fee-11e4-babe-e91da079cb8a_story.html

SCIENCE INSIDER                                        Oct. 8, 2014

By Jon Cohen and  Kai Kupferschmidt

GENEVA  ...the race is on to develop vaccines in a matter of months, instead of the years it typically takes. But even if one of the current candidates works, many questions remain. How fast can companies make millions of vaccine doses? When should they start production? And who will foot the multimillion-dollar bill?

Read Full Story

http://news.sciencemag.org/africa/2014/10/push-gamble-big-mass-production-ebola-vaccines